Basilea Pharmaceutica AG
SIX:BSLN

Watchlist Manager
Basilea Pharmaceutica AG Logo
Basilea Pharmaceutica AG
SIX:BSLN
Watchlist
Price: 44.45 CHF -1.77% Market Closed
Market Cap: 538.8m CHF

Operating Margin
Basilea Pharmaceutica AG

29.3%
Current
13%
Average
-6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
29.3%
=
Operating Profit
61.2m
/
Revenue
208.5m

Operating Margin Across Competitors

Basilea Pharmaceutica AG
Glance View

Market Cap
537.4m CHF
Industry
Biotechnology

Basilea Pharmaceutica AG engages in the development and commercialization of pharmaceutical products. The company is headquartered in Basel, Basel-Stadt and currently employs 154 full-time employees. The company went IPO on 2004-03-25. The firm operates in one segment, which is the discovery, development and commercialization of innovative pharmaceutical products to meet the needs of patients with cancer and infectious diseases. The company launched two hospital brands, Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of severe bacterial infections. Additionally It is conducting clinical studies with two targeted drug candidates for the treatment of a range of cancers and have a number of preclinical assets in both cancer and infectious diseases in its portfolio.

BSLN Intrinsic Value
60.08 CHF
Undervaluation 26%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
29.3%
=
Operating Profit
61.2m
/
Revenue
208.5m
What is the Operating Margin of Basilea Pharmaceutica AG?

Based on Basilea Pharmaceutica AG's most recent financial statements, the company has Operating Margin of 29.3%.

Back to Top